Type II latency can be seen in the nasopharyngeal carcinoma with the expression of EBNA1, LMP1, LMP2s (latent membrane protein 2s), EBERs, and BARTs. This evidence concerns the gene PDLIM7 and nasopharyngeal carcinoma.